New Relic, Inc. (NEWR) is now among the bigger bargains in its industry.
Within the last year the price ranged from $50 – 109 and there is a wide opportunity to get in. Its next earnings report will be released on May 12, 2020.

AMAG Pharmaceuticals, Inc.(AMAG)

move, based on 2 analysts offering 12 month price targets for Amag Pharmaceuticals in the last 3 months. The average price target is $12.50 with a high forecast of $16.00 and a low forecast of $9.00. The average price target represents a 31.58% increase from the last price of $9.50.

Analysts like Ken Cacciatore from Cowen & Co. believe that we could see stock price minimum $9.00.

Another prominent analyst, Douglas Tsao of H.C. Wainwright rates AMAG as a Buy. The rating was made just 7 days ago.

AMAG Pharmaceuticals, Inc.(AMAG) Recent News Reports

On average 1.5 articles are written each week about AMAG but this week 1 article were written and they were 61% Bullish and 39% Bearish.

AMAG Pharmaceuticals, Inc. Target Levels

Some other stocks to consider in this sector are:

CRM
MSFT
IBM